• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 5 - Utilization of Clinical Pathways in Oncology

Video

Drs Peter Salgo, John L. Fox, Ira M. Klein, Michael Kolodziej, Bryan Loy, Irwin W. Tischler, and Christopher Sweeney discuss the high costs associated with oncology drugs and explain how clinical pathway are being implemented to manage drug utilization and incentivize providers.

Drs Loy and Kolodziej explain when considering and developing a clinical pathway, together providers and payers evaluate the clinical efficacy, tolerability/side effect profile, and cost effectiveness of treatments.

Although most pathways are based on evidence, various factors may still make providers unable to resistant to utilizing a specific from utilizing a specific algorithm when treating patients in their practice, comment Drs Tischler and Klein. Dr Tischler notes that if a provider is against utilizing the suggested pathway, there is little that can change his or her thinking. Dr Klein adds that if the provider chooses not to adhere to the pathway, payers may not reimburse for the treatment. Where there may be a dearth of clinical evidence, Dr Sweeney stresses the utility of consensus guidelines in providing optimal care for each cancer patient.


Related Videos
Ronesh Sinha, MD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
dr robert sidbury
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.